Intra-Cellular Ther
(ITCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308,698 | 466,062 | 695,056 | 141,569 | 149,517 |
| Marketable Securities | 694,118 | 542,250 | 329,601 | 335,804 | 350,174 |
| Receivables | 166,500 | 145,608 | 145,714 | 131,157 | 114,018 |
| Inventories | 26,283 | 23,539 | 20,082 | 15,949 | 11,647 |
| TOTAL | $1,307,364 | $1,271,731 | $1,264,251 | $690,527 | $667,799 |
| Non-Current Assets | |||||
| PPE Net | 1,468 | 2,005 | 1,445 | 1,522 | 1,654 |
| Other Non-Current Assets | 58,080 | 50,709 | 54,808 | 54,987 | 58,842 |
| TOTAL | $59,548 | $52,714 | $56,253 | $56,509 | $60,496 |
| Total Assets | $1,366,912 | $1,324,445 | $1,320,504 | $747,036 | $728,295 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,074 | 10,338 | 17,548 | 11,532 | 11,452 |
| Accrued Expenses | 99,989 | 81,036 | 62,085 | 49,658 | 55,308 |
| TOTAL | $205,704 | $166,113 | $161,775 | $134,801 | $123,545 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,748 | 13,506 | 14,117 | 12,737 | 13,326 |
| TOTAL | $12,748 | $13,506 | $14,117 | $12,737 | $13,326 |
| Total Liabilities | $218,452 | $179,619 | $175,892 | $147,538 | $136,871 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,328 | 106,017 | 105,667 | 105,575 | 96,807 |
| Common Shares | 11 | 11 | 11 | 10 | 10 |
| Retained earnings | -1,691,836 | -1,674,951 | -1,648,627 | -1,632,407 | -1,617,160 |
| Other shareholders' equity | 191 | 1,629 | -668 | -430 | 104 |
| TOTAL | $1,148,460 | $1,144,826 | $1,144,612 | $599,498 | $591,424 |
| Total Liabilities And Equity | $1,366,912 | $1,324,445 | $1,320,504 | $747,036 | $728,295 |